Elevance Health Reports Second Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Elevance Health Inc. (ELV) Tops Q2 EPS by 25c
July 19, 2023 6:01 AM EDTElevance Health Inc. (NYSE: ELV) reported Q2 EPS of $9.04, $0.25 better than the analyst estimate of $8.79. Revenue for the quarter came in at $43.4 billion versus the consensus estimate of $41.64 billion.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
... More